Lipitor user Doris Ryan has filed a product liability lawsuit against Pfizer Inc., alleging that their drug Lipitor caused her to develop type-2 diabetes. Ryan took Lipitor to help lower her cholesterol, but now reportedly faces new health concerns.
Lipitor is designed to decrease the levels of LDL or “bad” cholesterol and total cholesterol levels. Since the body produces some cholesterol on its own, drugs like Lipitor can help lower cholesterol levels in patients whose bodies make it difficult to control cholesterol levels through diet and exercise alone. However, some research, and hundreds of Lipitor lawsuits, allegedly suggest that the drug increases the risk of developing type-2 diabetes.
The Lipitor diabetes lawsuit points out that in 2011, the Division of Metabolism and Endocrinology Products of the FDA requested that Pfizer change the labeling of the drug to reflect increased evidence of a link between the drug and diabetes. However, when the company changed the labeling in early 2012, it only included the phrase: Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor.
Ryan’s lawsuit contends that prior to this 2012 labeling change, Pfizer made no reference to the risk of Lipitor, and even when they did, they used thick jargon to conceal the risks of diabetes. The Lipitor diabetes lawsuit contends that this is part of a consistent pattern of concealing the risk of diabetes from patients like Ryan, preventing patients and their prescribing physicians from having the information they needed to make informed medical decisions, and putting them at risk of this metabolic disorder.
According to her lawsuit, Ryan was “very healthy” prior to taking Lipitor and took the drug “proactively” to reduce her risk of developing cardiovascular disease. However, developing diabetes has exposed her to the risk of complications including heart disease, blindness, nerve damage, and kidney disease. Type-2 diabetes is a lifelong illness that requires substantial adaptation by the patient, and can be a substantial financial burden.
The case is Doris Ryan v. Pfizer Incorporated, Case No. 2:14-6968, filed in the United States District Court for the District of West Virginia.
In general, Lipitor lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Lipitor Class Action Lawsuit Investigation
If you’re a woman who was diagnosed with type-2 diabetes while taking Lipitor, or were diagnosed with diabetes within 90 days or less of your last dose of Lipitor, you may be eligible for compensation. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
